In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

eHealth and Cardiology

What is eHealth and why is it relevant to cardiology today? Watch videos and case studies and read the latest science on this hot topic

Read more


A Horizon 2020 funded project to improve the prevention and treatment of Atrial Fibrillation

If you're involved in the management of patients with Atrial Fibrillation, then you’ll want to know more about CATCH ME – an exciting project that brings together the expertise of leading academic institutes, healthcare organisations and specialised professional organizations, with the aim of improving the care of patients with AFib.

Why the focus on Atrial Fibrillation?

Atrial Fibrillation (AFib) is the most common cardiac arrhythmia. A major cause of death, stroke and long-term disability in the elderly in Europe, it is a major threat to healthy ageing.

What is CATCH ME?

CATCH ME (Characterising Afib by Translating its Causes into Health Modifiers in the Elderly) aims to improve the prevention and treatment of atrial fibrillation and its complications. The goal is to develop and validate better disease management strategies based on the improved understanding of the main health modifiers (such as genes, drugs, and behaviour) leading to atrial fibrillation in the European population. More specifically, CATCH ME will:

  1. Identify the major health modifiers causing AF in the Elderly in Europe,
  2. Develop clinical tools that will personalise the prevention and management of AF patients, and
  3. Guide and strengthen future strategies to prevent, diagnose, and treat AF in Europe.

CATCH ME also aims to provide substantial answers to current AF uncertainties such as gender differences by clarifying the reasons why female European citizens seem to be protected more against AF compared to males, or why females are at higher stroke risk than males once they have developed AF.


As a consortium partner the ESC will use its expertise in translating scientific knowledge into practical tools that support health care professionals in keeping up to date and applying best practice guidelines. By using our extensive network of institutional and individual members, we ensure that these tools are delivered to the maximum number of health care professionals. These include:

  • State-of-the-art CATCH ME tools within the Afib section of the ESC Pocket Guideline app 
    Find out more ABOUT CATCH ME tools 
  • Unique CATCH ME app for patients to capture and transmit patients’ digital auto-anamnesis before each hospital visit and to educate patients as users on their disease and their category of AF - to be launched December 2016.
  • Online education programme – to be launched in 2017.

To find out more about CATCH ME, visit


You may also be interested in

CATCH ME Consortium:

  • The University Of Birmingham          
  • Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
  • Universiteit Maastricht           
  • Ludwig-Maximilians-Universitaet Muenchen
  • The Chancellor, Masters and Scholars of the University Of Oxford            
  • Universite Pierre Et Marie Curie - Paris 6     
  • Kompetenznetz Vorhofflimmern E.V.             
  • European Society of Cardiology ESC

N.B. CATCH ME is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633196